{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T08:23:54Z","timestamp":1763022234249,"version":"3.45.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["CTSA \u2013 UL1TR001439"],"award-info":[{"award-number":["CTSA \u2013 UL1TR001439"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007865","name":"University of Texas Medical Branch","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007913","name":"Institute for Translational Neuroscience","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007913","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Medicine Open"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ajmo.2023.100040","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T14:35:34Z","timestamp":1679495734000},"page":"100040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Association of Cardiovascular Medications With Adverse Outcomes in a Matched Analysis of a National Cohort of Patients With COVID-19"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1913-2778","authenticated-orcid":false,"given":"Leonard K.","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Fang","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1473-1766","authenticated-orcid":false,"given":"Jordan","family":"Westra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukaila A.","family":"Raji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4185-5294","authenticated-orcid":false,"given":"Mohanad","family":"Albayyaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Allencherril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Baillargeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajmo.2023.100040_bib0001","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.amjcard.2020.09.012","article-title":"Relation of statin use prior to admission to severity and recovery among COVID-19 inpatients","volume":"136","author":"Daniels","year":"2020","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ajmo.2023.100040_bib0002","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.jinf.2020.04.021","article-title":"Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis","volume":"81","author":"Zheng","year":"2020","journal-title":"J Infect"},{"issue":"15","key":"10.1016\/j.ajmo.2023.100040_bib0003","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/heartjnl-2020-317056","article-title":"Cardiovascular manifestations and treatment considerations in COVID-19","volume":"106","author":"Kang","year":"2020","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.ajmo.2023.100040_bib0004","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41418-020-0530-3","article-title":"COVID-19 infection: the perspectives on immune responses","volume":"27","author":"Shi","year":"2020","journal-title":"Cell Death Differ"},{"issue":"4","key":"10.1016\/j.ajmo.2023.100040_bib0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/21548331.2020.1772639","article-title":"Anti-coagulant and anti-platelet therapy in the COVID-19 patient: a best practices quality initiative across a large health system","volume":"48","author":"Watson","year":"2020","journal-title":"Hosp Pract (1995)"},{"key":"10.1016\/j.ajmo.2023.100040_bib0006","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.amjcard.2020.08.005","article-title":"The effect of anticoagulation use on mortality in COVID-19 infection","volume":"134","author":"Salah","year":"2020","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.ajmo.2023.100040_bib0007","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.ajmo.2023.100040_bib0008","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cmet.2020.06.015","article-title":"In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19","volume":"32","author":"Zhang","year":"2020","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.ajmo.2023.100040_bib0009","doi-asserted-by":"crossref","first-page":"403","DOI":"10.7861\/clinmedicine.17-5-403","article-title":"Statin therapy in patients with community-acquired pneumonia","volume":"17","author":"Grudzinska","year":"2017","journal-title":"Clin Med Lond"},{"issue":"10","key":"10.1016\/j.ajmo.2023.100040_bib0010","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1164\/rccm.201812-2328OC","article-title":"Simvastatin improves neutrophil function and clinical outcomes in pneumonia. A pilot randomized controlled clinical trial","volume":"200","author":"Sapey","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ajmo.2023.100040_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.877944","article-title":"The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: a multicenter, cohort study","volume":"10","author":"Al Sulaiman","year":"2022","journal-title":"Front Public Health"},{"issue":"1","key":"10.1016\/j.ajmo.2023.100040_bib0012","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.ajmo.2023.100040_bib0013","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ijid.2020.05.115","article-title":"Potential role of statins in COVID-19","volume":"96","author":"Lee","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ajmo.2023.100040_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2020.101054","article-title":"Antiviral effects of statins","volume":"79","author":"Gorabi","year":"2020","journal-title":"Prog Lipid Res"},{"issue":"4","key":"10.1016\/j.ajmo.2023.100040_bib0015","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"9","key":"10.1016\/j.ajmo.2023.100040_bib0016","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/jamacardio.2020.1855","article-title":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)","volume":"5","author":"Mehta","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"10","key":"10.1016\/j.ajmo.2023.100040_bib0017","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11906-022-01207-3","article-title":"Renin\u2013angiotensin\u2013aldosterone inhibitors and COVID-19 infection","volume":"24","author":"Tsampasian","year":"2022","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"10.1016\/j.ajmo.2023.100040_bib0018","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ajmo.2023.100040_bib0019","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/ajh\/hpac001","article-title":"Effects of renin\u2013angiotensin system inhibitors on mortality and disease severity of COVID-19 patients: a meta-analysis of randomized controlled trials","volume":"35","author":"Yin","year":"2022","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ajmo.2023.100040_bib0020","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/ajh\/hpab111","article-title":"Effects of renin-angiotensin-aldosterone inhibitors on early outcomes of hypertensive COVID-19 patients: a randomized triple-blind clinical trial","author":"Najmeddin","year":"2021","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ajmo.2023.100040_bib0021","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12916-021-01992-9","article-title":"Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: a retrospective cohort study","volume":"19","author":"de Abajo","year":"2021","journal-title":"BMC Med"},{"key":"10.1016\/j.ajmo.2023.100040_bib0022","first-page":"1","article-title":"The effects of antihypertensive medications on severity and outcomes of COVID19","author":"Agirbasli","year":"2022","journal-title":"J Hum Hypertens"},{"issue":"12","key":"10.1016\/j.ajmo.2023.100040_bib0023","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1007\/s11606-021-07155-z","article-title":"Risk of Covid-19-related hospitalization and more severe outcomes in Medicare beneficiaries treated with renin-angiotensin-aldosterone system inhibitors for hypertension","volume":"36","author":"Graham","year":"2021","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.ajmo.2023.100040_bib0024","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/HYPERTENSIONAHA.120.15143","article-title":"Effects of angiotensin II receptor blockers and ACE (angiotensin-converting enzyme) inhibitors on virus infection, inflammatory status, and clinical outcomes in patients with COVID-19 and hypertension: a single-center retrospective study","volume":"76","author":"Yang","year":"2020","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.ajmo.2023.100040_bib0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.3594","article-title":"Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19","volume":"4","author":"Baral","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.ajmo.2023.100040_bib0026","article-title":"Pharmacological protection of vascular endothelium in acute COVID-19","volume":"73","author":"Bednarz","year":"2022","journal-title":"J Physiol Pharmacol"},{"issue":"7","key":"10.1016\/j.ajmo.2023.100040_bib0027","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11886-020-01328-8","article-title":"The role of anticoagulation in COVID-19-induced hypercoagulability","volume":"22","author":"Rico-Mesa","year":"2020","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"10.1016\/j.ajmo.2023.100040_bib0028","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2020.05.001","article-title":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19","volume":"76","author":"Paranjpe","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ajmo.2023.100040_bib0029","doi-asserted-by":"crossref","first-page":"e2180","DOI":"10.1002\/rmv.2180","article-title":"Anticoagulation outcomes in hospitalized Covid-19 patients: a systematic review and meta-analysis of case-control and cohort studies","volume":"31","author":"Kamel","year":"2021","journal-title":"Rev Med Virol"},{"issue":"17","key":"10.1016\/j.ajmo.2023.100040_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.2021.17272","article-title":"Effect of antithrombotic therapy on clinical outcomes in outpatients with clinically stable symptomatic COVID-19","volume":"326","author":"Connors","year":"2021","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.ajmo.2023.100040_bib0031","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018624","article-title":"Anticoagulation before hospitalization is a potential protective factor for COVID-19: insight from a French multicenter cohort study","volume":"10","author":"Chocron","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ajmo.2023.100040_bib0032","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1182\/blood.2020006941","article-title":"Impact of anticoagulation prior to COVID-19 infection: a propensity score\u2013matched cohort study","volume":"136","author":"Tremblay","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ajmo.2023.100040_bib0033","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/joim.13205","article-title":"Direct oral anticoagulant use and risk of severe COVID-19","volume":"289","author":"Flam","year":"2021","journal-title":"J Intern Med"},{"key":"10.1016\/j.ajmo.2023.100040_bib0034","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.ajmo.2023.100040_bib0035","unstructured":"United States Census Bureau. Geographic levels. Available at:. https:\/\/www.census.gov\/programs-surveys\/economic-census\/guidance-geographies\/levels.html. Accessed February 21, 2023."},{"key":"10.1016\/j.ajmo.2023.100040_bib0036","article-title":"Dalton JE. A unified approach to measuring the effect size between two groups using SAS\u00ae","author":"Yang","year":"2012","journal-title":"Published online"},{"issue":"25","key":"10.1016\/j.ajmo.2023.100040_bib0037","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.ajmo.2023.100040_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2020.10.001","article-title":"Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: results from the CORONADO study","volume":"47","author":"Cariou","year":"2021","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.ajmo.2023.100040_bib0039","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.amjcard.2020.08.004","article-title":"Meta-analysis of effect of statins in patients with COVID-19","volume":"134","author":"Kow","year":"2020","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.ajmo.2023.100040_bib0040","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.dsx.2020.08.023","article-title":"Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection","volume":"14","author":"Hariyanto","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.ajmo.2023.100040_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.742273","article-title":"The effect of statins on clinical outcome among hospitalized patients with COVID-19: a multi-centric cohort study","volume":"13","author":"Umakanthan","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajmo.2023.100040_bib0042","doi-asserted-by":"crossref","DOI":"10.2174\/2772434417666220902153823","article-title":"Atorvastatin efficacy in the management of mild to moderate hospitalized COVID-19: a pilot randomized triple-blind placebo-controlled clinical trial","author":"Hejazi","year":"2022","journal-title":"Recent Adv Antiinfect Drug Discov"},{"issue":"1","key":"10.1016\/j.ajmo.2023.100040_bib0043","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1186\/s12879-022-07570-5","article-title":"Statin and aspirin as adjuvant therapy in hospitalised patients with SARS-CoV-2 infection: a randomised clinical trial (RESIST trial)","volume":"22","author":"Ghati","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ajmo.2023.100040_bib0044","doi-asserted-by":"crossref","first-page":"12047","DOI":"10.1038\/s41598-022-16357-2","article-title":"Protective effects of statins on COVID-19 risk, severity and fatal outcome: a nationwide Swedish cohort study","volume":"12","author":"Santosa","year":"2022","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.ajmo.2023.100040_bib0045","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1002\/jmv.27710","article-title":"Survival of the hospitalized patients with COVID-19 receiving atorvastatin: a randomized clinical trial","volume":"94","author":"Ghafoori","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.ajmo.2023.100040_bib0046","article-title":"Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial","volume":"376","author":"Investigators","year":"2022","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.ajmo.2023.100040_bib0047","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamainternmed.2020.3539","article-title":"Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy","volume":"180","author":"Grasselli","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"11","key":"10.1016\/j.ajmo.2023.100040_bib0048","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025289","article-title":"Renin-angiotensin aldosterone system inhibitors and COVID-19: a systematic review and meta-analysis revealing critical bias across a body of observational research","volume":"11","author":"Loader","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.ajmo.2023.100040_bib0049","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2213-2600(21)00214-9","article-title":"Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial","volume":"9","author":"Bauer","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"10","key":"10.1016\/j.ajmo.2023.100040_bib0050","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1473-3099(20)30434-5","article-title":"Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study","volume":"20","author":"Carsana","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajmo.2023.100040_bib0051","doi-asserted-by":"crossref","first-page":"274","DOI":"10.18433\/jpps32723","article-title":"Efficacy and safety of anticoagulants for COVID-19 patients in the intensive care unit: a systematic review and meta-analysis","volume":"25","author":"Yulistiani","year":"2022","journal-title":"J Pharm Pharm Sci"},{"issue":"4","key":"10.1016\/j.ajmo.2023.100040_bib0052","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s41999-021-00504-5","article-title":"Protecting older patients with cardiovascular diseases from COVID-19 complications using current medications","volume":"12","author":"Alves","year":"2021","journal-title":"Eur Geriatr Med"},{"issue":"4","key":"10.1016\/j.ajmo.2023.100040_bib0053","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266922","article-title":"Effect of common maintenance drugs on the risk and severity of COVID-19 in elderly patients","volume":"17","author":"Fung","year":"2022","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ajmo.2023.100040_bib0054","first-page":"e0705","article-title":"Critical influenza and COVID-19\u2014A comparative nationwide case-control study","volume":"4","author":"Larsson","year":"2022","journal-title":"Crit Care Explor"},{"issue":"9","key":"10.1016\/j.ajmo.2023.100040_bib0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.18087\/cardio.2021.9.n1680","volume":"61","author":"Tarlovskaya","year":"2021","journal-title":"Kardiologiia"},{"issue":"6","key":"10.1016\/j.ajmo.2023.100040_bib0056","first-page":"251","article-title":"Susceptibility and risk of SARS-COV-2 infection among middle-aged and older adults in Tarragona area, Spain","volume":"158","author":"Satu\u00e9-Gracia","year":"2022","journal-title":"Med Cl\u00ednica Engl Ed"},{"key":"10.1016\/j.ajmo.2023.100040_sbref0057","series-title":"Identification of Biomarkers, New Treatments, and Vaccines for COVID-19. Advances in Experimental Medicine and Biology","first-page":"205","article-title":"Association of in-hospital use of statins, aspirin, and renin-angiotensin-aldosterone inhibitors with mortality and ICU admission due to COVID-19","author":"Vahedian-Azimi","year":"2021"},{"key":"10.1016\/j.ajmo.2023.100040_bib0058","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2147\/PPA.S245365","article-title":"Reasons for nonadherence to statins\u2014A systematic review of reviews","volume":"14","author":"Ingersgaard","year":"2020","journal-title":"Patient Prefer Adherence"},{"year":"2023","series-title":"COVID data tracker weekly review","key":"10.1016\/j.ajmo.2023.100040_bib0059"}],"container-title":["American Journal of Medicine Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667036423000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667036423000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T08:19:45Z","timestamp":1763021985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667036423000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":59,"alternative-id":["S2667036423000109"],"URL":"https:\/\/doi.org\/10.1016\/j.ajmo.2023.100040","relation":{},"ISSN":["2667-0364"],"issn-type":[{"type":"print","value":"2667-0364"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Cardiovascular Medications With Adverse Outcomes in a Matched Analysis of a National Cohort of Patients With COVID-19","name":"articletitle","label":"Article Title"},{"value":"American Journal of Medicine Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajmo.2023.100040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100040"}}